Phase IIB Randomized, Placebo Controlled Trial of Pioglitizone for Oral Leukoplakia (An Interconsortium Collaborative Study)
|Effective start/end date
|9/1/09 → 8/31/10
- UNIVERSITY OF WISCONSIN-MADISON
- NIH NATIONAL CANCER INSTITUTE (NCI)
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.